Market closed
Palvella Therapeutics Inc/$PVLA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Palvella Therapeutics Inc
Palvella Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases. It is developing a broad pipeline of product candidates based on its patented QTORIN platform, with an initial focus on serious, rare genetic skin diseases. Palvella's lead product candidate, QTORIN 3.9% rapamycin anhydrous gel, is currently in clinical development for microcystic lymphatic malformations (microcystic LMs) and cutaneous venous malformations.
Ticker
$PVLA
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
-
Website
PVLA Metrics
BasicAdvanced
$274M
-
-$7.83
-
-
Price and volume
Market cap
$274M
52-week high
$29.27
52-week low
$18.60
Financial strength
Current ratio
7.33
Quick ratio
6.945
Management effectiveness
Return on assets (TTM)
-18.39%
Return on equity (TTM)
-59.37%
Valuation
Growth
Earnings per share change (TTM)
-1,268.99%
PVLA News
AllArticlesVideos
Palvella Therapeutics Announces Late-Breaking Oral Presentation at the 15th World Congress of Pediatric Dermatology
GlobeNewsWire·3 days ago
Palvella Therapeutics Reports Full Year 2024 Financial Results and Provides Corporate Update
GlobeNewsWire·5 days ago
Palvella Therapeutics to Host Full Year 2024 Financial Results Conference Call on March 31, 2025
GlobeNewsWire·3 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Palvella Therapeutics Inc stock?
Palvella Therapeutics Inc (PVLA) has a market cap of $274M as of April 05, 2025.
What is the P/E ratio for Palvella Therapeutics Inc stock?
The price to earnings (P/E) ratio for Palvella Therapeutics Inc (PVLA) stock is 0 as of April 05, 2025.
Does Palvella Therapeutics Inc stock pay dividends?
No, Palvella Therapeutics Inc (PVLA) stock does not pay dividends to its shareholders as of April 05, 2025.
When is the next Palvella Therapeutics Inc dividend payment date?
Palvella Therapeutics Inc (PVLA) stock does not pay dividends to its shareholders.
What is the beta indicator for Palvella Therapeutics Inc?
Palvella Therapeutics Inc (PVLA) does not currently have a Beta indicator.